Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,906 INR | +2.27% | +6.72% | +17.35% |
Sales 2024 * | 35.01B 420M 33.44B | Sales 2025 * | 40.58B 487M 38.76B | Capitalization | 296B 3.55B 283B |
---|---|---|---|---|---|
Net income 2024 * | 5.64B 67.62M 5.39B | Net income 2025 * | 7.06B 84.67M 6.74B | EV / Sales 2024 * | 8.49 x |
Net Debt 2024 * | 1.32B 15.81M 1.26B | Net cash position 2025 * | 4.41B 52.91M 4.22B | EV / Sales 2025 * | 7.18 x |
P/E ratio 2024 * |
49.5
x | P/E ratio 2025 * |
39.6
x | Employees | 5,095 |
Yield 2024 * |
0.64% | Yield 2025 * |
0.75% | Free-Float | 45.82% |
Latest transcript on J. B. Chemicals & Pharmaceuticals Limited
1 day | +2.27% | ||
1 week | +6.72% | ||
Current month | +15.57% | ||
1 month | +15.57% | ||
3 months | +12.48% | ||
6 months | +40.20% | ||
Current year | +17.35% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 04/10/20 | |
Bharat Dhanani
COO | Chief Operating Officer | - | - |
Sujay Rajhans
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 30/08/20 | |
Akshay Tanna
BRD | Director/Board Member | 40 | 11-06 |
Gaurav Trehan
BRD | Director/Board Member | 48 | 09/02/21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.43% | - | |
0.00% | 117 M€ | +1.54% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 1,906 | +2.27% | 2,921 |
26/04/24 | 1,864 | +0.48% | 973 |
25/04/24 | 1,855 | +1.69% | 7,046 |
24/04/24 | 1,824 | +2.30% | 4,047 |
23/04/24 | 1,783 | -0.16% | 4,204 |
Delayed Quote Bombay S.E., April 29, 2024 at 11:00 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.35% | 3.47B | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |
- Stock Market
- Equities
- 506943 Stock